BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
82.98
+3.09 (3.87%)
At close: Aug 18, 2026, 4:00 PM EDT
83.20
+0.22 (0.27%)
After-hours: Aug 18, 2026, 7:54 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $16.22 billion as of August 18, 2026. Its market cap has increased by 65.35% in one year.
Market Cap
16.22B
Enterprise Value
18.87B
1-Year Change
65.35%
Ranking
Category
Stock Price
$82.98
ChartMarket Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $16.22B, an increase of 388.65%. That is a compound annual growth rate of 24.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 16.22B | 10.05% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 19.46B |
| Ascendis Pharma | 16.25B |
| Jazz Pharmaceuticals | 16.12B |
| Exelixis | 12.96B |
| BioMarin Pharmaceutical | 12.90B |
| Corcept Therapeutics | 12.67B |
| Arrowhead Pharmaceuticals | 12.53B |
| Madrigal Pharmaceuticals | 12.13B |